Biowest fetal bovine serum USDA origin

Ended Purchase Order Awarded Last action

Contract number
75N93024P00914
Awardee
Awarding agency
Obligated
$24,717

Award facts

Contract value 100% obligated
$24,717.02 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Lakewood Ranch, FL 34211, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a firm fixed-price purchase order contract to Biowest USA Inc. for the procurement of BIOWEST FETAL BOVINE SERUM USDA ORIGIN. The contract has a ceiling value of $24,717.02 and a period of performance ending on September 16, 2024. The contract does not have a set-aside designation. As NIAID is a research-focused agency within the U.S. Department of Health and Human Services, this contract is likely to support the agency's efforts in areas such as immunology, infectious disease research, and vaccine development.

Quick answers

Who was awarded contract 75N93024P00914?

75N93024P00914 was awarded to Biowest USA Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2024.

How much is contract 75N93024P00914 worth?

The government has obligated $24,717 on 75N93024P00914.

Was contract 75N93024P00914 competed?

The extent of competition for 75N93024P00914 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award